Volume 10, Issue 2 (Summer 2009)                   jrehab 2009, 10(2): 0-0 | Back to browse issues page

XML Persian Abstract Print


1- Medical School of Tarbiat Modares University, Tehran, Iran.
Abstract:   (11320 Views)

Objective: Chronic obstructive pulmonary disease (COPD) is characterized with air flow restriction that this limitation is not refundable completely. This study is carried out in order to determine the effect of regular walking as rehabilitation plan on clinical status of chronic obstructive pulmonary disease (COPD) patients with moderate severity of disease.
Materials & Methods: In this quasi experimental study 100 patients were selected simply from convenient samples of Isfahan hospitals and finally were assigned into two groups as control group (n=30)and experimental group (n=50).Data collection tools include Demographic data questionnaire and observation checklist of clinical status for measuring respiratory status and self report questionnaire about walking doing. All of tools complited in 3 stages: before intervention, end four week and two month after intervention. Data were analyzed by repeated measurement ANOVA, Paired T test and Independent T test.
Results: There was no significant difference in mean score of dyspnea (P=0.1), sputum quality (P=0.45), respiration pattern (P=0.06) and lung auscultation (P=0.06) of control group at different stages of research, but in experimental group, these variants were significant (P-values were 0.01, <0.001, 0.004 and 0.03).
Conclusion: Regular walking as rehabilitation plan in moderate chronic obstructive pulmonary disease patients improves clinical status of them (decrease of cough and sputum and regular respiration pattern and lung auscultation) and pulmonary function.

Full-Text [PDF 234 kb]   (2257 Downloads)    
Type of Study: Applicable | Subject: General
Received: 26/08/2009 | Accepted: 13/10/2015 | Published: 13/10/2015

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.